Macrophage scavenger receptor A (SR-A) is a multifunctional, multiligand pattern recognition receptor with roles in innate immunity, apoptotic cell clearance, and age-related degenerative pathologies, such as atherosclerosis and Alzheimer's disease. Known endogenous SR-A ligands are polyanionic and include modified lipoproteins, advanced glycation end products, and extracellular matrix proteins. No native plasma ligands have been identified, but it is known that SR-A recognition of unidentified serum components mediates integrin-independent macrophage adhesion, which may drive chronic local inflammation. In this study, we used a high-throughput fractionation and screening method to identify novel endogenous SR-A ligands that may mediate macrophage adhesion. SR-A was found to recognize the exchangeable apolipoproteins A-I and E (apo A-I and apo E, respectively) in both lipid-free and lipid-associated form, suggesting the shared amphipathic alpha-helix as a potential recognition motif. Adhesion of RAW 264.7 macrophages to surfaces coated with apo A-I and apo E4 proved to be integrin-independent and could be blocked by anti-SR-A antibodies. The presence of apo A-I and apo E in pathological deposits, such as atherosclerotic lesions and neurotoxic Alzheimer's plaques, suggests a possible contribution of SR-A-dependent adhesion of macrophages to an inflammatory microenvironment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793687 | PMC |
| http://dx.doi.org/10.1021/bi9013769 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association of Biopsy-proven Nonalcoholic Fatty Liver Disease with Obesity and Apolipoproteins.
J Gastrointestin Liver Dis
December 2024
Department of Gastroenterology, Gulhane School of Medicine, Ankara, Turkey.
Background And Aims: Insulin resistance is considered the most important key mechanism in the development of nonalcoholic fatty liver disease (NAFLD). Some studies have reported that hyperinsulinemia decreases the hepatic secretion of apolipoprotein (Apo) B. Chronic hyperinsulinemia in NAFLD may be responsible for the accumulation of triglycerides in hepatocytes.
View Article and Find Full Text PDFRisk factors associated with the false positive of cardiopulmonary exercise test in the diagnosis of coronary heart disease.
BMC Cardiovasc Disord
November 2024
Department of Pharmacy, The First Affiliated Hospital of Ningbo University, No.247 Renmin Road, Ningbo, 315020, Zhejiang, China.
Article Synopsis
- The study aimed to identify factors associated with false positives in cardiopulmonary exercise tests (CPET) for diagnosing coronary heart disease (CHD), focusing on blood glucose and lipid levels.
- A comparison was made between 103 subjects with false positive results and 65 with true positive results, noting that males, smokers, and diabetes patients were less likely to be in the false positive group, which also had higher HDL and lower blood glucose levels.
- The findings suggest that fasting blood glucose (FBG) and glycosylated hemoglobin (GHb) might help differentiate between true and false positives, especially in females, making FBG a useful predictor of false positives in suspected CHD cases.
Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression.
Mol Cell Proteomics
December 2024
Northwestern University Transplant Outcomes Research Collaborative (NUTORC), Comprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Electronic address:
Article Synopsis
- - Cirrhosis affects 2 to 5 million Americans, with most patients experiencing compensated cirrhosis, yet many can develop serious complications that severely shorten life expectancy.
- - Identifying high-risk patients with compensated cirrhosis is crucial for improving their care and directing them to specialty treatment, as not all patients receive this level of care.
- - This pilot study identified 209 differentially expressed proteoforms in the plasma of cirrhosis patients at various stages, highlighting potential biomarkers that could help in early diagnosis and risk assessment.
Relationship Between Serum Uromodulin as a Marker of Kidney Damage and Metabolic Status in Patients with Chronic Kidney Disease of Non-Diabetic Etiology.
Int J Mol Sci
October 2024
Center of Laboratory Diagnostic, University Clinical Center of Vojvodina, 21000 Novi Sad, Serbia.
Chronic kidney disease (CKD) is often associated with dyslipidemia, marked by lipid abnormalities that can worsen kidney function and increase cardiovascular risk. A promising biomarker for evaluating kidney function and metabolic status in chronic kidney disease (CKD) is serum uromodulin (sUmod). This study sought to further investigate the relationship between sUmod levels and metabolic status in non-diabetic CKD patients.
View Article and Find Full Text PDFUNCONTROLLED TYPE 2 DIABETES MELLITUS MODULATED PLASMA LEVELS OF LIPID CATABOLIC PROTEINS.
Georgian Med News
October 2024
Department of Chemistry, College of Science, University of Kirkuk, Iraq.
Background And Objectives: This research is considered the first of its kind in Kirkuk City to study the activity of lecithin cholesterol acyl transferase (LCAT), the levels of apolipoprotein A-1 (Apo A-1), and Fatty acid binding protein-4 (FABP4) and some biochemical variables in T2DM patients who uncontrolled the disease (glycated hemoglobin (HbA1C)˃8%) and compared with patients who controlled the disease (HbA1C˂7%) and healthy controls (HbA1C≤5.5%), and find the correlation among them.
Methods: This research included 184 persons [128 patients (70 uncontrolled DM and 58 controlled DM + 56 healthy patients] aged (40-80) years from both sexes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!